NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024.

Humans Melanoma / therapy Skin Neoplasms / therapy Neoplasm Staging Medical Oncology / standards

Journal

Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515

Informations de publication

Date de publication:
Jul 2024
Historique:
medline: 18 7 2024
pubmed: 18 7 2024
entrez: 17 7 2024
Statut: ppublish

Résumé

The NCCN Guidelines for Cutaneous Melanoma (termed Melanoma: Cutaneous) provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients. These NCCN Guidelines Insights focus on the update to neoadjuvant systemic therapy options and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Cutaneous Melanoma.

Identifiants

DOI: 10.6004/jnccn.2024.0036 PMID: 39019054
pubmed: 39019054
doi: 10.6004/jnccn.2024.0036
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

290-298

Auteurs

Susan M Swetter (SM)

1Stanford Cancer Institute.

Douglas Johnson (D)

2Vanderbilt-Ingram Cancer Center.

Mark R Albertini (MR)

3University of Wisconsin Carbone Cancer Center.

Christopher A Barker (CA)

4Memorial Sloan Kettering Cancer Center.

Sarah Bateni (S)

5O'Neal Comprehensive Cancer Center at UAB.

Joel Baumgartner (J)

6UC San Diego Moores Cancer Center.

Shailender Bhatia (S)

7Fred Hutchinson Cancer Center.

Christopher Bichakjian (C)

8University of Michigan Rogel Cancer Center.

Genevieve Boland (G)

9Mass General Cancer Center.

Sunandana Chandra (S)

10Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Bartosz Chmielowski (B)

11UCLA Jonsson Comprehensive Cancer Center.

Dominick DiMaio (D)

12Fred & Pamela Buffett Cancer Center.

Roxana Dronca (R)

13Mayo Clinic Comprehensive Cancer Center.

Ryan C Fields (RC)

14Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

Martin D Fleming (MD)

15The University of Tennessee Health Science Center.

Anjela Galan (A)

16Yale Cancer Center/Smilow Cancer Hospital.

Samantha Guild (S)

17AIM at Melanoma.

John Hyngstrom (J)

18Huntsman Cancer Institute at the University of Utah.

Giorgos Karakousis (G)

19Abramson Cancer Center at the University of Pennsylvania.

Kari Kendra (K)

20The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Maija Kiuru (M)

21UC Davis Comprehensive Cancer Center.

Julie R Lange (JR)

22The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Ryan Lanning (R)

23University of Colorado Cancer Center.

Theodore Logan (T)

24Indiana University Melvin and Bren Simon Comprehensive Cancer Center.

Daniel Olson (D)

25The UChicago Medicine Comprehensive Cancer Center.

Anthony J Olszanski (AJ)

26Fox Chase Cancer Center.

Patrick A Ott (PA)

27Dana-Farber/Brigham and Women's Cancer Center.

Merrick I Ross (MI)

28The University of Texas MD Anderson Cancer Center.

Luke Rothermel (L)

29Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

April K Salama (AK)

30Duke Cancer Institute.

Rohit Sharma (R)

31UT Southwestern Simmons Comprehensive Cancer Center.

Joseph Skitzki (J)

32Roswell Park Comprehensive Cancer Center.

Emily Smith (E)

8University of Michigan Rogel Cancer Center.

Katy Tsai (K)

33UCSF Helen Diller Family Comprehensive Cancer Center.

Evan Wuthrick (E)

34Moffitt Cancer Center.

Yan Xing (Y)

35City of Hope National Medical Center.

Nicole McMillian (N)

36National Comprehensive Cancer Network.

Sara Espinosa (S)

36National Comprehensive Cancer Network.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › NCCN Guidelines® Insights: Melanoma:...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Naevus et mélanomes › Mélanome › NCCN Guidelines® Insights: Melanoma:...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Tumeurs cutanées › NCCN Guidelines® Insights: Melanoma:...
questionsmedicales.fr › Diagnostic › Pronostic › Stadification tumorale › NCCN Guidelines® Insights: Melanoma:...
questionsmedicales.fr › Professions de santé › Médecine › Médecine interne › Oncologie médicale › NCCN Guidelines® Insights: Melanoma:...